Works matching IS 03407004 AND DT 2004 AND VI 53 AND IP 7
Results: 10
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 609, doi. 10.1007/s00262-003-0491-7
- By:
- Publication type:
- Article
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 589, doi. 10.1007/s00262-003-0492-6
- By:
- Publication type:
- Article
Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 633, doi. 10.1007/s00262-003-0493-5
- By:
- Publication type:
- Article
CD44v6: a target for antibody-based cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 567, doi. 10.1007/s00262-003-0494-4
- By:
- Publication type:
- Article
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 651, doi. 10.1007/s00262-003-0495-3
- By:
- Publication type:
- Article
T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 625, doi. 10.1007/s00262-003-0496-2
- By:
- Publication type:
- Article
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 617, doi. 10.1007/s00262-003-0498-0
- By:
- Publication type:
- Article
α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 580, doi. 10.1007/s00262-004-0499-7
- By:
- Publication type:
- Article
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 600, doi. 10.1007/s00262-004-0500-5
- By:
- Publication type:
- Article
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 642, doi. 10.1007/s00262-004-0501-4
- By:
- Publication type:
- Article